About one-third of participants lost 20 percent or more. LaValle explains that the 16.6 percent average weight loss seen with the Wegovy pill reflects several factors, including the higher 25 mg dose, the 64-week length of the trial, the diet and activity coaching participants received and the strong biological effects of semaglutide as a GLP-1
The prospect of funding lifelong drug regimens for large populations is financially daunting and raises concerns about long-term sustainability
2.4 Genetic alteration analysis Genetic alterations in the GLP-1R gene were analyzed using cBioPortal (version: 3.6.20, Based on TCGA Pan-Cancer Atlas Studies datasets, we calculated the frequency of GLP-1R gene alterations, including mutations, copy number alterations, and deletions using the Cancer Types Summary module [35]
Adding maintenance time pushes total treatment to 12 to 18 months minimum for significant weight loss goals
doi: 10.1016/j.regpep.2010.04.009 49 SammsRJChristeMECollinsKAPirroVDrozBAHollandAKet al
